204 related articles for article (PubMed ID: 37608285)
1. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
[TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy.
Yao P; Wang X; Wang Q; Dai Q; Peng Y; Yuan Q; Mou N; Lv S; Weng B; Wang Y; Sun F
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514014
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
4. pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
Tao J; Diao L; Chen F; Shen A; Wang S; Jin H; Cai D; Hu Y
Mol Pharm; 2021 Jan; 18(1):74-86. PubMed ID: 33084332
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Ni R; Song G; Fu X; Song R; Li L; Pu W; Gao J; Hu J; Liu Q; He F; Zhang D; Huang G
Biomaterials; 2020 Feb; 232():119730. PubMed ID: 31918224
[TBL] [Abstract][Full Text] [Related]
7. Self-amplified chain-shattering cinnamaldehyde-based poly(thioacetal) boosts cancer chemo-immunotherapy.
Zong Q; Li J; Xiao X; Du X; Yuan Y
Acta Biomater; 2022 Dec; 154():97-107. PubMed ID: 36210042
[TBL] [Abstract][Full Text] [Related]
8. Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer.
Badparvar F; Marjani AP; Salehi R; Ramezani F
Sci Rep; 2024 Apr; 14(1):8567. PubMed ID: 38609391
[TBL] [Abstract][Full Text] [Related]
9. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
[TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy.
Tu Y; Xiao X; Dong Y; Li J; Liu Y; Zong Q; Yuan Y
Biomaterials; 2022 Oct; 289():121795. PubMed ID: 36108580
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.
Wang Y; Yuan Q; Feng W; Pu W; Ding J; Zhang H; Li X; Yang B; Dai Q; Cheng L; Wang J; Sun F; Zhang D
J Nanobiotechnology; 2019 Oct; 17(1):103. PubMed ID: 31581948
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle.
Swetha KL; Paul M; Maravajjala KS; Kumbham S; Biswas S; Roy A
J Control Release; 2023 Apr; 356():93-114. PubMed ID: 36841286
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
16. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
Wang X; Cheng R; Zhong Z
Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
Nie J; Cheng W; Peng Y; Liu G; Chen Y; Wang X; Liang C; Tao W; Wei Y; Zeng X; Mei L
Drug Deliv; 2017 Nov; 24(1):1124-1138. PubMed ID: 28789585
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
20. Roxithromycin and rhEGF Co-loaded Reactive Oxygen Species Responsive Nanoparticles for Accelerating Wound Healing.
Ding J; Chen D; Hu J; Zhang D; Gou Y; Wu Y
Curr Drug Deliv; 2024; 21(5):753-762. PubMed ID: 37183469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]